Panome Bio Inc.
St. Louis, MO
- UEI
- D1WQKF3J33Q4
- CAGE
- 9GGZ4
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 4340 Duncan Ave #286, St. Louis, MO 63110, USA
- Website
- panomebio.com
- Founded
- 2022
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Biomarker discovery in colon cancer through next-generation metabolomics | National Cancer Institute (NIH) | $2,045,814 |
Quick answers
Is Panome Bio Inc. registered in SAM.gov?
Panome Bio Inc.'s SAM.gov registration expired on September 18, 2026.
What is Panome Bio Inc.'s most recent federal award?
Panome Bio Inc.'s most recent federal grant award is Biomarker discovery in colon cancer through next-generation metabolomics (R44CA295318), from National Cancer Institute (NIH), on September 2, 2025.
On GovTribe
See Panome Bio Inc.'s full federal record
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors